Related Experiment Video
Updated: Jul 23, 2025
08:08
Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
14.2K
Pulmonary Hypertension: A Contemporary Review
Shelsey Johnson1,2, Natascha Sommer3, Katherine Cox-Flaherty4
1The Pulmonary Center, Division of Pulmonary, Allergy, Sleep and Critical Care, Boston University School of Medicine, Boston, Massachusetts.
Summary
Recent advances in pulmonary hypertension (PH) offer new insights into its mechanisms, diagnosis, and treatment. Key findings highlight progress in pulmonary vascular biology and novel therapies like sotatercept for pulmonary arterial hypertension.
Area of Science:
- Cardiovascular Medicine
- Pulmonary Medicine
- Vascular Biology
Background:
- Pulmonary hypertension (PH) encompasses several conditions, including pulmonary arterial hypertension (PAH), PH with lung disease, and chronic thromboembolic PH (CTEPH).
- Understanding the pathogenetic mechanisms, epidemiology, and diagnostic approaches for these conditions is crucial for effective management.
- Recent breakthroughs necessitate an update on the current state of PH research and clinical practice.
Approach:
- This review synthesizes key basic, translational, and clinical research findings in PH.
- It incorporates recent revisions to the PH definition, emphasizing early detection.
- The review provides guidance on diagnosing and managing PH in clinical practice, considering cardiopulmonary comorbidities.
Key Points:
- Cutting-edge progress in translational pulmonary vascular biology is detailed.
- Emphasis is placed on the early detection of PH through revised diagnostic criteria.
- Evolving treatment strategies for PH, particularly in patients with comorbidities, are discussed.
Conclusions:
- The review highlights groundbreaking data on sotatercept for treating pulmonary arterial hypertension.
- It underscores the importance of integrating new research into clinical practice for improved patient outcomes.
- Continued research in pulmonary vascular disease is essential for advancing PH management.
